|
|||||
|
|

Infrastructure and defense services provider Parsons (NYSE:PSN) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 7.5% year on year to $1.60 billion. The company’s full-year revenue guidance of $6.65 million at the midpoint came in 99.9% below analysts’ estimates. Its non-GAAP profit of $0.75 per share was 4.9% below analysts’ consensus estimates.
Is now the time to buy PSN? Find out in our full research report (it’s free for active Edge members).
Parsons' fourth quarter results prompted a significant negative market reaction, as the company missed Wall Street’s revenue and profit expectations. Management attributed the underperformance to contract timing issues and the completion of a large confidential contract, which reduced overall revenue and backlog. CEO Carey Smith described the environment as “dynamic,” highlighting a 43-day government shutdown that delayed procurement activity and led to project deferrals, especially in the federal solutions segment. Despite these setbacks, Smith emphasized continued strength in critical infrastructure and noted that several new contract wins helped offset some of the volume decline.
Looking ahead, the company’s guidance is shaped by cautious optimism around upcoming federal spending and infrastructure opportunities, while acknowledging persistent risks. Management cited robust demand in both U.S. and Middle Eastern markets and expects mid-single-digit organic revenue growth, supplemented by accretive acquisitions. CFO Matt Ofilos cautioned that “domestic budget uncertainty, a competitive labor market, and government procurement delays” remain headwinds, but noted Parsons’ record funded backlog and strong pipeline as supportive factors. Smith added, “We remain focused on margin expansion and capital deployment to drive long-term shareholder value.”
Management pointed to the end of a major contract and delays in federal procurement as key reasons for the quarter’s softness, but highlighted growth in core markets and new contract wins as positive offsets.
Parsons’ outlook for the next year is centered on infrastructure growth, federal budget opportunities, and ongoing margin improvement, but tempered by procurement and budgetary uncertainties.
In the coming quarters, the StockStory team will be watching (1) the pace of new contract awards and backlog replenishment, particularly in the federal solutions segment; (2) the ability of recent acquisitions to drive cross-selling and margin improvement; and (3) the progress of Middle East infrastructure and event-driven projects. Execution in these areas will be central to tracking Parsons’ performance amid ongoing federal budget uncertainty and procurement delays.
Parsons currently trades at $60.58, down from $70.21 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).
The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
| Feb-13 | |
| Feb-12 | |
| Feb-11 | |
| Feb-11 | |
| Feb-11 | |
| Feb-11 | |
| Feb-11 | |
| Feb-11 | |
| Feb-11 | |
| Feb-11 | |
| Feb-10 | |
| Feb-09 | |
| Feb-09 | |
| Feb-05 | |
| Feb-05 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite